Bruner C A, Webb R C
Department of Physiology, University of Michigan Medical School, Ann Arbor 48109-0622.
Clin Exp Hypertens A. 1987;9(11):1745-62. doi: 10.3109/10641968709158970.
Isolated tail arteries from stroke-prone spontaneously hypertensive rats (SHRSP), but not normotensive Wistar-Kyoto (WKY) rats, exhibit oscillatory contractions in response to norepinephrine. To establish whether this vascular abnormality is secondary to elevated arterial pressure, SHRSP and WKY were treated with hydralazine and hydrochlorothiazide from weaning to 4 months of age. Hydralazine and hydrochlorothiazide treatment significantly attenuated hypertension development in SHRSP (systolic blood pressure: control SHRSP = 219 +/- 9 mmHg; treated SHRSP = 143 +/- 5 mmHg at 15 weeks of age). Helically-cut tail artery strips from all rats were mounted in tissue baths for isometric force recording and exposed to norepinephrine (6 x 10(-10)-6 x 10(-6) M) for 20 min at each concentration. Oscillatory activity was defined as the sum of the magnitudes of all phasic contractions occurring during the final 10 min of NE incubation. There was no significant difference in the magnitude of oscillatory activity between hydralazine/hydrochlorothiazide-treated SHRSP and control SHRSP. From these results we conclude that norepinephrine-induced oscillatory activity in SHRSP is a primary vascular abnormality that is not secondary to high blood pressure.
来自易中风自发性高血压大鼠(SHRSP)而非正常血压的Wistar-Kyoto(WKY)大鼠的离体尾动脉,对去甲肾上腺素会出现振荡性收缩。为确定这种血管异常是否继发于动脉血压升高,从断奶至4月龄,对SHRSP和WKY大鼠用肼屈嗪和氢氯噻嗪进行治疗。肼屈嗪和氢氯噻嗪治疗显著减弱了SHRSP的高血压发展(收缩压:对照SHRSP = 219±9 mmHg;15周龄时治疗的SHRSP = 143±5 mmHg)。将所有大鼠螺旋形切割的尾动脉条安装在组织浴槽中进行等长力记录,并在每个浓度下用去甲肾上腺素(6×10⁻¹⁰ - 6×10⁻⁶ M)处理20分钟。振荡活性定义为去甲肾上腺素孵育最后10分钟内所有相性收缩幅度的总和。肼屈嗪/氢氯噻嗪治疗的SHRSP与对照SHRSP之间的振荡活性幅度没有显著差异。从这些结果我们得出结论,去甲肾上腺素诱导的SHRSP振荡活性是一种原发性血管异常,并非继发于高血压。